Charles River Laboratories International Inc. (CRL) Financial Statements (2025 and earlier)

Company Profile

Business Address 251 BALLARDVALE ST
WILMINGTON, MA 01887
State of Incorp.
Fiscal Year End December 31
Industry (SIC) 8731 - Commercial Physical and Biological Research (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in millions)
Annual | Quarterly

9/30/2024
MRQ
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments277234242229239196
Cash and cash equivalents277234241228238195
Short-term investments   1111
Restricted cash and investments664300
Receivables780752650618514472
Inventory, net of allowances, customer advances and progress billings380256199186161128
Inventory380256199186161128
Prepaid expense888994975353
Other current assets     00
Other undisclosed current assets7810185685447
Total current assets:1,6091,4391,2741,2011,021898
Noncurrent Assets
Operating lease, right-of-use asset394392293178140✕
Property, plant and equipment    1,1241,044933
Long-term investments and receivables244312    
Long-term investments244312    
Intangible assets, net (including goodwill)3,9593,8053,7732,5972,2301,858
Goodwill3,0952,8502,7121,8091,5411,247
Intangible assets, net (excluding goodwill)8649551,061788689611
Restricted cash and investments      
Deferred income tax assets4041403845✕
Other noncurrent assets309148353353213144
Other undisclosed noncurrent assets1,6401,4661,291  23
Total noncurrent assets:6,5866,1645,7504,2903,6712,958
TOTAL ASSETS:8,1957,6037,0245,4914,6933,856
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities397426673479409310
Employee-related liabilities✕✕✕246207159137
Accounts payable16920619812211166
Accrued liabilities228220229150139107
Deferred revenue242264220208172✕
Debt643503931
Business combination, contingent consideration, liability  13    
Other liabilities2032051381029171
Contract with customer, liability✕✕✕✕✕✕145
Other undisclosed current liabilities208180    
Total current liabilities:1,0551,0921,033840710558
Noncurrent Liabilities
Long-term debt and lease obligation, including:2,6472,7082,6641,9301,8501,637
Long-term debt, excluding current maturities      1,627
Finance lease, liability 2628252628✕
Other undisclosed long-term debt and lease obligation2,6212,6792,3861,7481,70610
Liabilities, other than long-term debt834780583495429238
Deferred income tax liabilities191216240217167✕
Liability, pension and other postretirement and postemployment benefits   75737959
Other liabilities223175243205183179
Operating lease, liability419390253156116✕
Business combination, contingent consideration, liability   25   
Other undisclosed noncurrent liabilities   153833784
Total noncurrent liabilities:3,4813,4883,3992,5072,3161,959
Total liabilities:4,5364,5794,4323,3473,0262,518
Temporary equity, carrying amount574253252919
Equity
Equity, attributable to parent3,5972,9762,5352,1151,6351,317
Common stock111000
Treasury stock, value     (0)
Additional paid in capital1,9061,8051,7181,6281,5321,448
Accumulated other comprehensive loss(196)(262)(165)(139)(178)(173)
Retained earnings1,8871,43398162528042
Equity, attributable to noncontrolling interest554432
Total equity:3,6022,9812,5392,1181,6381,320
TOTAL LIABILITIES AND EQUITY:8,1957,6037,0245,4914,6933,856

Income Statement (P&L) ($ in millions)
Annual | Quarterly

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Revenues4,1293,9763,5402,9242,6212,266
Cost of revenue
(Cost of Goods and Services Sold)		      
Gross profit:4,1293,9763,5402,9242,6212,266
Operating expenses(885)(812)(745)(641)(607)(509)
Other undisclosed operating loss(2,627)(2,513)(2,206)(1,850)(1,663)(1,426)
Operating income:617651590433351331
Nonoperating income (expense)10131(35)1011414
Other nonoperating income (expense)9631(36)1001213
Interest and debt expense(141)(59)(74)(86)(61)(64)
Income from continuing operations before equity method investments, income taxes:577623481447304282
Other undisclosed income from continuing operations before income taxes4     
Income from continuing operations before income taxes:581623481447304282
Income tax expense(101)(130)(82)(82)(50)(54)
Income from continuing operations:480493399365254227
Income before gain (loss) on sale of properties:✕✕✕399365254229
Income from discontinued operations      2
Net income:480493399365254229
Net loss attributable to noncontrolling interest(6)(6)(8)(1)(2)(2)
Net income attributable to parent:475486391364252226
Preferred stock dividends and other adjustments3(4)    
Other undisclosed net loss available to common stockholders, basic      
Net income available to common stockholders, diluted:478483391364252226

Comprehensive Income ($ in millions)
Annual | Quarterly

9/30/2024
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
Net income:480493399365254229
Other comprehensive income (loss)(9)24(15)(5)(25)
Other undisclosed comprehensive income (loss)73(103)(29)56(0)(1)
Comprehensive income:545392374406249203
Comprehensive loss, net of tax, attributable to noncontrolling interest(5)(3)(9)(2)(2)(1)
Comprehensive income, net of tax, attributable to parent:540389365403247202

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: